Black Rock Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,446,366 shares of REGN stock, worth $6.12 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares

8,446,366

Previous 8,568,654 1.43%

Holding current value

$6.12 Billion

Previous $8.25 Billion 7.64%

% of portfolio

0.2%

Previous 0.19%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $108 Million - $131 Million	-122,288 Reduced 1.43%	8,446,366 $8.88 Billion
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $55.1 Million - $60.6 Million	-61,053 Reduced 0.71%	8,568,654 $8.25 Billion
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $190 Million - $217 Million	-245,602 Reduced 2.77%	8,629,707 $7.58 Billion
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $146 Million - $178 Million	-210,673 Reduced 2.32%	8,875,309 $7.3 Billion
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $233 Million - $276 Million	-332,318 Reduced 3.53%	9,085,982 $6.53 Billion
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $171 Million - $208 Million	251,483 Added 2.74%	9,418,300 $7.74 Billion
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $226 Million - $246 Million	-320,426 Reduced 3.38%	9,166,817 $6.61 Billion
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $486,152 - $613,499	-847 Reduced 0.01%	9,487,243 $6.54 Billion
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $53.1 Million - $71.6 Million	-96,861 Reduced 1.01%	9,488,090 $5.61 Billion
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $15.4 Million - $18.1 Million	-25,920 Reduced 0.27%	9,584,951 $6.69 Billion
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $133 Million - $164 Million	244,009 Added 2.61%	9,610,871 $6.07 Billion
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $191 Million - $227 Million	333,312 Added 3.69%	9,366,862 $5.67 Billion
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $4.27 Billion - $5.05 Billion	9,033,550 New	9,033,550 $5.05 Billion

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account